In NSCLC, mutp53 promotes the expression of the pro-angiogenic factors IL8 and GRO-α through activation of inhibitor of DNA binding 4 (ID4) and hence, GRO-α. This evidence concerns the gene ID4 and non-small cell lung carcinoma.